Argent Financial Group’s Pfizer PFE Stock Holding History

Argent Financial Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.07M	Buy	+71,505	New	+$2.09M	0.25%	104

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Argent Financial Group's PFE Position: Q3 2024 in Review

Argent Financial Group opened a new position in Pfizer (PFE) in Q3 2024: 71,505 shares worth $2.07M. The stake represents 0.25% of the portfolio and ranks #104 among its holdings.

2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

Argent Financial Group held 71,505 shares of Pfizer worth $2.07M as of Q3 2024.
Pfizer was a new Argent Financial Group position in Q3 2024.
Pfizer made up 0.25% of Argent Financial Group's portfolio in Q3 2024, its #104 holding.
2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Argent Financial Group's 13F filing for Q3 2024, filed 13 Nov 2024.